• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-21A
Device Problems Backflow (1064); Material Split, Cut or Torn (4008)
Patient Problems Aortic Regurgitation (1716); Heart Failure (2206); Heart Failure/Congestive Heart Failure (4446); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 09/28/2020
Event Type  malfunction  
Manufacturer Narrative
Further information regarding this event has been requested.The investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2020, the sjm trifecta valve was explanted (originally implanted on (b)(6) 2014) and replaced with an m-size perceval sutureless aortic valve (manufacturer: livanova).A tear was observed on the explanted valve from the rcc and the ncc stent post toward the ncc side.Pannus formed on the inflow side of the valve, also.The patient's state was unstable before the explant.The patient remained stable throughout the re-do procedure, and is in stable condition postoperatively.
 
Manufacturer Narrative
The valve was reportedly explanted due to a tear and pannus formation.The torn leaflet was previously excised and sent for pathological examination by the hospital.A tear was found in the base of leaflet 3, consistent with explant damage.The outflow of stent post 2 was covered with pannus, and outflow pannus was found at stent post 1, which extended onto the base of leaflet 3.No inflammation or significant calcifications were found.The device history record was reviewed to ensure each manufacturing and inspection operation was performed and the product met all specifications at the time of commercialization.In the absence of any calcification or evidence for infection, the reported event is consistent with a non-calcific leaflet tear.A non-calcific leaflet tear is a form of structural valve deterioration (svd), which is a well-known complication from valve replacement surgery.A non-calcific leaflet tear is commonly attributed to increased operational leaflet stress but may also be related to biological factors which result in tissue degeneration characterized by loss of collagen.In this case, the torn leaflet was excised in the field and therefore the tear site could not be examined and the cause of the reported tear could not be determined; however, the outflow pannus and reported inflow pannus had the potential to induce increased stress on adjacent leaflets and created an unbalanced stress relief distribution between all leaflets during coaptation, which may lead to leaflet tears and reduced durability.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10717877
MDR Text Key214167680
Report Number2135147-2020-00449
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/26/2015
Device Model NumberTF-21A
Device Catalogue NumberTF-21A
Device Lot Number4250659
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer10/15/2020
Was the Report Sent to FDA? No
Date Manufacturer Received01/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-